Back to 
UBS Group AG
UBS Group AG
NGEN2 quarters
Position history for UBS Group AG's holdings in NERVGEN PHARMA CORP
UBS Group AG holds 379,726 shares of NGEN (NERVGEN PHARMA CORP), worth $782,236 as of 2026-Q2. The position was increased (+517.3% shares). NGEN represents 0.0% of UBS Group AG's portfolio.
Current Value
$782,236
Current Shares
379,726
Total Value Change
+$550,317
Total Shares Change
+318,209
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA